Simone Reuter Selected Research

Simone Reuter Research Topics

Disease

20	Neoplasms (Cancer) 01/2016 - 11/2008
7	Inflammation (Inflammations) 09/2012 - 11/2008
7	Leukemia 01/2012 - 07/2009
5	Multiple Myeloma 01/2013 - 10/2010
4	Colonic Neoplasms (Colon Cancer) 01/2016 - 08/2010
3	Breast Neoplasms (Breast Cancer) 01/2013 - 10/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 01/2011
2	Neoplasm Metastasis (Metastasis) 09/2012 - 10/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011 - 11/2010
2	Carcinogenesis 11/2010 - 08/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2009 - 03/2009
1	Colorectal Neoplasms (Colorectal Cancer) 09/2012
1	Ascites 09/2012
1	Myalgia 04/2012
1	Chronic Disease (Chronic Diseases) 10/2011
1	Carcinoma (Carcinomatosis) 01/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2011
1	Musculoskeletal Diseases (Musculoskeletal Disease) 11/2010
1	Kidney Neoplasms (Kidney Cancer) 11/2010
1	Osteoporosis 10/2010
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2010
1	Acute Erythroblastic Leukemia (Erythroleukemia) 03/2009
1	Anemia 11/2008

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2012 - 07/2009
6	CurcuminIBA 06/2011 - 12/2008
6	CytokinesIBA 06/2011 - 11/2008
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011 - 11/2008
5	LigandsIBA 01/2013 - 08/2010
5	NF-kappa B (NF-kB)IBA 10/2011 - 12/2008
5	Transcription Factors (Transcription Factor)IBA 10/2011 - 11/2008
3	nimbolideIBA 01/2016 - 11/2010
3	Cyclin D1IBA 02/2011 - 08/2010
2	futoxideIBA 01/2016 - 08/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 01/2011
2	Death Domain ReceptorsIBA 01/2016 - 01/2011
2	Angiogenic ProteinsIBA 01/2016 - 08/2010
2	cardamoninIBA 01/2013 - 12/2011
2	thiocolchicosideIBA 04/2012 - 11/2010
2	colchicosideIBA 04/2012 - 11/2010
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2011 - 06/2011
2	ResveratrolIBA 06/2011 - 01/2011
2	SurvivinIBA 02/2011 - 08/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 08/2010
1	Diphosphonates (Bisphosphonates)IBA 01/2013
1	Denosumab FDA Link 01/2013
1	Biomarkers (Surrogate Marker)IBA 09/2012
1	Capecitabine (Xeloda)FDA Link 09/2012
1	Therapeutic UsesIBA 09/2012
1	Ursolic AcidIBA 09/2012
1	Proteasome InhibitorsIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 11/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 06/2011
1	GenisteinIBA 06/2011
1	LycopeneIBA 06/2011
1	Antineoplastic Agents (Antineoplastics)IBA 05/2011
1	flavoneIBA 02/2011
1	Phosphotransferases (Kinase)IBA 02/2011
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2011
1	LimoninsIBA 01/2011
1	Vincristine (Oncovin)FDA LinkGeneric 01/2011
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2011
1	Cysteine (L-Cysteine)FDA Link 11/2010
1	I-kappa B KinaseIBA 11/2010
1	TriterpenesIBA 11/2010
1	Analgesics (Analgesic Drugs)IBA 11/2010
1	embelinIBA 10/2010
1	quinone (benzoquinone)IBA 10/2010
1	TNF Receptor-Associated Factor 1IBA 08/2010
1	Vitamin E FDA LinkGeneric 08/2010
1	Palm OilIBA 08/2010
1	CaspasesIBA 08/2010
1	TocotrienolsIBA 08/2010
1	EsterasesIBA 08/2010
1	aclacinomycinsIBA 03/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2009
1	Hemin (Panhematin)FDA Link 03/2009
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2009
1	Glutathione (Reduced Glutathione)IBA 02/2009
1	Acetylcysteine (Siran)FDA LinkGeneric 02/2009
1	AntioxidantsIBA 02/2009

Therapy/Procedure

2	Therapeutics 11/2011 - 08/2010
1	Ayurvedic Medicine (Siddha Medicine) 10/2011